Thereby, we validated the downregulation of the stem cell markers Smoc2, Lgr5 and Olfm4, as well as the repression of several genes involved in the Wnt/β-catenin signaling and/or Notch signaling in Ap4-deficient adenomas (Fig. 4c). The gene discussed is SMOC2; the disease is adenoma.